Gain Access to exclusive preclinical content.
Complete the form below to gain access to mattis aliquet nunc aliquam tempor. We’ll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
Beta-Hydroxybutyrate inhibits NLRP3-Mediated inflammation and delays progressive renal failure during primary hyperoxaluria related kidney stone Disease

Shrikant R. Mulay, Beatriz Suarez-Alvarez, Steffanie Steiger, Mohsen Honarpisheh, Julian Marschner, Jyaysi Desai, Hans-Joachim Anders, “Beta-Hydroxybutyrate inhibits NLRP3-Mediated inflammation and delays progressive renal failure during primary hyperoxaluria related kidney stone Disease,” ERA-EDTA 2016 conference abstract TO027.